Active-ingredient Dossier
Cabotegravir
Active-ingredient Dossier for Cabotegravir (integrase strand transfer inhibitor). Australian brands, products, PBS listings, PBAC outcomes — compiled by…
- Brand: CABENUVA
- Brand: VOCABRIA
- Brand: APRETUDE
- Therapeutic area: Infectious Disease
What is
Cabotegravir Cabotegravir is an integrase strand transfer inhibitor.
Therapeutic areas
Cabotegravir is registered in infectious disease, with 3 brands containing this ingredient.
Sponsor landscape
ViiV Healthcare markets cabotegravir in Australia.
PBS and regulatory activity
One brand containing cabotegravir has PBS-listed items, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome on record is 1 September 2023, and the latest AusPAR is 8 August 2022.